23andMe Patent Creates Controversy

A patent issued to 23andMe, Inc. last month has created some controversy, and in response, the biotech company, based in Mountain View, California, has posted its side of the story on the 23andMe blog. The patent, U.S. Patent No. 8,543,339, which is…
By: McDonnell Boehnen Hulbert & Berghoff LLP